Wuxi Biologics Cayman Inc. earnings per share and revenue

WXIBF earnings per share for the last semiannual are 0.04 USD whereas the estimation was 0.04 USD which accounts for 22.00% surprise. Company revenue for the same period amounts to 1.20 B USD despite the estimated figure of 1.18 B USD. Estimated earnings per share for the next semiannual are 0.06 USD, and revenue is expected to reach 1.08 B USD. Also watch annual changes over time to get a bigger picture of WXIBF earnings per share and revenue dynamics.